Detalles de la búsqueda
1.
Effectiveness of bevacizumab exposure beyond disease progression in patients with non-small-cell lung cancer: analyses of the ARIES observational cohort study.
Pharmacoepidemiol Drug Saf
; 25(5): 569-77, 2016 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-26748833
2.
Model Checking Techniques for Assessing Functional Form Specifications in Censored Linear Regression Models.
Stat Sin
; 22(2): 509-530, 2012 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-23825917
3.
FIR: Efficacy, Safety, and Biomarker Analysis of a Phase II Open-Label Study of Atezolizumab in PD-L1-Selected Patients With NSCLC.
J Thorac Oncol
; 13(11): 1733-1742, 2018 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-29775807
4.
Estimation of treatment effects in weighted log-rank tests.
Contemp Clin Trials Commun
; 8: 147-155, 2017 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-29696204
5.
Isolating the Role of Bevacizumab in Elderly Patients With Previously Untreated Nonsquamous Non-Small Cell Lung Cancer: Secondary Analyses of the ECOG 4599 and PointBreak Trials.
Am J Clin Oncol
; 39(5): 441-7, 2016 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-25628268
6.
Erlotinib therapy after initial platinum doublet therapy in patients with EGFR wild type non-small cell lung cancer: results of a combined patient-level analysis of the NCIC CTG BR.21 and SATURN trials.
Transl Lung Cancer Res
; 4(4): 465-74, 2015 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-26380188
7.
Effectiveness and safety of post-induction phase bevacizumab treatment for patients with non-small-cell lung cancer: results from the ARIES observational cohort study.
Target Oncol
; 10(4): 509-16, 2015 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-25559289
8.
Rejoinder to Letter to the Editor "The Hazards of Period Specific and Weighted Hazard Ratios".
Stat Biopharm Res
; 12(4): 520-521, 2020 Oct 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-34191985
9.
Safety and effectiveness of bevacizumab-containing treatment for non-small-cell lung cancer: final results of the ARIES observational cohort study.
J Thorac Oncol
; 9(9): 1332-9, 2014 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-25122429
10.
The association of rash severity with overall survival: findings from patients receiving erlotinib for pancreatic cancer in the community setting.
Pancreas
; 42(1): 32-6, 2013 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-22699203
11.
Bevacizumab maintenance in patients with advanced non-small-cell lung cancer, clinical patterns, and outcomes in the Eastern Cooperative Oncology Group 4599 Study: results of an exploratory analysis.
J Thorac Oncol
; 7(11): 1707-12, 2012 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-23059774
12.
If the ratio of hazards r(t)=λe(t)/λc(t) does not depend on time t then the proportional hazards assumption holds.
J Thorac Oncol
; 8(12): e116, 2013 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-24389451
13.
Phase II study of carboxyamidotriazole in patients with advanced renal cell carcinoma refractory to immunotherapy: E4896, an Eastern Cooperative Oncology Group Study.
Cancer
; 104(11): 2392-9, 2005 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-16222691
14.
Functional form diagnostics for Cox's proportional hazards model.
Biometrics
; 60(1): 75-84, 2004 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-15032776
Resultados
1 -
14
de 14
1
Próxima >
>>